Joshua Marcus, MD
Neurological Surgery · Danbury, CTNPI 1609010719
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $98,332 of the $141,922 with a category attached, or 69.3%. 29 manufacturers reported payments, led by Si-bone, Inc. at 45.9% of the total. Among neurological surgery clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 435 payments — averaging $326.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$65K
- Globus Medical$34K
- Premia Spine, Ltd.$18K
- Depuy Synthes Products, Inc.$11K
- Johnson & Johnson$3K
- Boston Scientific$3K
- plus $9K from 23 others
Across 3 payments — averaging $33,333 each. An ownership or investment interest held by the physician or an immediate family member.
- Vesalio, Inc.$100K
What the payments were for
- Consulting fees$98,33269%
- Speaking & faculty fees$15,60011%
- Travel & lodging$11,5578%
- Food & beverage$16,41412%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 83 | $65,188 |
| Globus Medical(2 entities) | 34 | $33,563 |
| Premia Spine, Ltd. | 3 | $17,582 |
| Depuy Synthes Products, Inc. | 5 | $10,538 |
| Johnson & Johnson(2 entities) | 125 | $3,148 |
| Boston Scientific | 52 | $2,773 |
| Microvention, Inc. | 21 | $2,604 |
| Medtronic(2 entities) | 22 | $1,885 |
| Penumbra, Inc. | 18 | $948 |
| Route 92 Medical, Inc. | 2 | $685 |
| Nevro Corp. | 11 | $677 |
| Stryker | 12 | $509 |
| Saluda Medical Americas, Inc. | 6 | $475 |
| Orthofix Medical, Inc. | 13 | $216 |
| DJO, LLC | 3 | $175 |
| Cardiva Medical, Inc. | 5 | $149 |
| Contego Medical, Inc | 1 | $122 |
| Imperative Care, Inc | 1 | $120 |
| CSL Behring | 3 | $89 |
| Cerapedics Inc. | 2 | $88 |
| E.r. Squibb & Sons, L.L.C. | 4 | $88 |
| Ossdsign USA Incorporated | 1 | $77 |
| 4web, Inc. | 1 | $47 |
| Lemaitre Vascular, Inc. | 2 | $39 |
| Biotronik NRO, Inc. | 1 | $37 |
| Phenox Inc. | 1 | $33 |
| Microtransponder, Inc. | 1 | $31 |
| Carlsmed, Inc. | 1 | $26 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IFUSE IMPLANT SYSTEM$57,197
- TOPS$17,582
- RISE-L$13,873
- TLIF$8,250
- RISE-L . RISE-L A/L$6,000
- iFuse Implant$3,892
- RISE$1,585
- CREO 5.5$1,496
- CALIBER$1,429
- INTELLIS$938
- GENERAL PAIN MANAGEMENT$819
- Senza$388
- Evoke$317
- Penumbra System$237
- SPECTRA WAVEWRITER$233
- Spine$187
- UNID_PASS$170
- 8F Base Camp Sheath System$165
- RED 72$164
- Penumbra Coil 400$155
How this compares
$141,922 in reported general payments places this provider in the 90th percentile of 94 neurological surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 16 | $9,674 |
| Gabapentin | 37 | $326 |
| Methocarbamol | 20 | $142 |
| Meloxicam | 34 | $98 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $13 | $9,67416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 94 neurological surgery providers in Connecticut.
Other neurological surgery in Danbury
- Jonathon LebovitzDanbury$12K
- Jeffrey GilliganDanbury$12K
- Scott SandersonDanbury$6K
- Gary KocharianDanbury$5K
- Ramon BatsonDanbury$3K
- Murat GunelNew Haven$839K
- Sanjay RathiNorth Haven$541K
- Patrick SenatusSouth Windsor$309K
- Ahmed KhanNew Britain$250K
- Abraham MintzShelton$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.